-
公开(公告)号:US20230355834A1
公开(公告)日:2023-11-09
申请号:US18311205
申请日:2023-05-02
Applicant: BOSTON SCIENTIFIC SCIMED, INC.
Inventor: Philip David Dorgan , Edward Joseph Devlin , Conor O’Sullivan , John Murphy , Mark Looney , Paul O’Farrell
CPC classification number: A61L24/08 , A61L24/0015 , A61L24/0031 , A61L2300/418 , A61L2400/04
Abstract: In some aspects, the present disclosure pertains to injectable polysaccharide-based hydrogels that comprises an anionic polysaccharide, a cationic crosslinking agent and a hemostatic agent. In some aspects, the present disclosure pertains to medical devices containing such injectable polysaccharide-based hydrogels, to kits that contain such injectable polysaccharide-based hydrogels, and to methods of using such injectable polysaccharide-based hydrogels.